| Lipopeptide Immunisation With GTU-multiHIV Trial (NCT01492985) | ANRS, Emerging Infectious Diseases | 2013-07-01 |
| A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc (NCT01894776) | Ottawa Hospital Research Institute | 2013-06-01 |
| FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir (NCT01777997) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2013-04-25 |
| A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure (NCT01641367) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2013-02-22 |
| A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen (NCT01714414) | Michael Hoelscher | 2012-12-01 |
| Re-boosting of HIV-1 Infected Subjects With Vacc-4x (NCT01712256) | Bionor Immuno AS | 2012-12-01 |
| Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera (NCT01701895) | Prema Menezes, PhD, PA-C | 2012-10-01 |
| Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART) (NCT01704781) | Bionor Immuno AS | 2012-09-01 |
| Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART (NCT01627678) | Bionor Immuno AS | 2012-09-01 |
| Treatment With Probiotics (Saccharomyces Boulardii) and Its Role in Bacterial Translocation and Immune Reconstitution in VIH Infection. (NCT01908049) | Parc de Salut Mar | 2012-08-01 |
| Effect of Cytoreductive Chemotherapy and a CCR5 Coreceptor Antagonist on HIV-1 Eradication (NCT02486510) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2012-07-01 |
| SkIn, Muscle and Bone Aging Determinants in HIV Infected-patients. (NCT04067219) | University Hospital, Bordeaux | 2012-05-03 |
| Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors (NCT01480713) | IrsiCaixa | 2012-05-01 |
| HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women (NCT01315353) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2012-04-04 |
| Study of Options for Second-Line Effective Combination Therapy (SELECT) (NCT01352715) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2012-03-13 |
| Rosuvastatin to Decrease Residual Immune Activation in HIV Infection (NCT01874743) | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 2012-03-01 |
| Phase I/IIa Dose-escalation Clinical Study of VAC-3S (NCT01549119) | InnaVirVax | 2012-02-01 |
| Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated (NCT01529749) | Felipe Garcia | 2012-02-01 |
| Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen (NCT01400412) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2012-01-17 |
| Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV (NCT05215704) | Erasmus Medical Center | 2012-01-01 |
| Renal Transplantation and Raltegravir in HIV-Infected Patients (NCT01453192) | ANRS, Emerging Infectious Diseases | 2011-12-01 |
| Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma (NCT01352117) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-11-18 |
| HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy (NCT04266002) | Hôpital Franco-Britannique-Fondation Cognacq-Jay | 2011-11-01 |
| Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate (NCT01426438) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-11-01 |
| Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation (NCT01515813) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-11-01 |
| Sevelamer for Reducing Endotoxemia and Immune Activation (NCT01543958) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-11-01 |
| A Study of Doravirine (MK-1439) in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005) (NCT01466985) | Merck Sharp & Dohme LLC | 2011-10-21 |
| Reducing Cardiovascular Disease (CVD) Risk in HIV on Antiretroviral Therapy Over 12 Months (NCT01436136) | Holdsworth House Medical Practice | 2011-10-01 |
| Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients (NCT01348308) | ANRS, Emerging Infectious Diseases | 2011-09-01 |
| High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART (NCT01403051) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-09-01 |
| Rifaximin as a Modulator of Microbial Translocation and Immune Activation (NCT01466595) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-09-01 |
| Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003) (NCT01353898) | Merck Sharp & Dohme LLC | 2011-06-21 |
| Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus (NCT01338883) | Tobira Therapeutics, Inc. | 2011-06-01 |
| Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis (NCT01427738) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-06-01 |
| Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (NCT01335529) | ANRS, Emerging Infectious Diseases | 2011-05-01 |
| Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women (NCT01296152) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-05-01 |
| Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells (NCT01351025) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-04-14 |
| Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T (NCT04201782) | Sangamo Therapeutics | 2011-03-18 |
| Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts (NCT01928407) | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 2011-02-23 |
| Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults (NCT01309243) | Gilead Sciences | 2011-02-01 |
| Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive (NCT01489046) | Bristol-Myers Squibb | 2011-02-01 |
| The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART (NCT01319383) | University of North Carolina, Chapel Hill | 2011-02-01 |
| A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1 (NCT01266902) | Janssen R&D Ireland | 2011-02-01 |
| Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants (NCT01082692) | Inovio Pharmaceuticals | 2011-01-01 |
| Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals (NCT01286259) | University of California, San Francisco | 2011-01-01 |
| HIV Internet Sex Study: Internet-based STI/HIV Prevention for HIV+ Internet Users (NCT02887508) | University of Connecticut | 2010-12-01 |
| Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF (NCT01252940) | Gilead Sciences | 2010-11-01 |
| MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2) (NCT01152255) | Merck Sharp & Dohme LLC | 2010-10-10 |
| Comorbidity and Aging With HIV (NCT01466582) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2010-10-01 |
| A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen) (NCT01213316) | Merck Sharp & Dohme LLC | 2010-10-01 |
| Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients (NCT01019551) | Objectif Recherche Vaccins SIDA | 2010-09-01 |
| Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression (NCT01511809) | IRCCS San Raffaele | 2010-09-01 |
| Pregabalin Trial In HIV Neuropathic Pain (NCT01145417) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-01 |
| A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART (NCT01378156) | GeoVax, Inc. | 2010-06-01 |
| DCVax Plus Poly ICLC in Healthy Volunteers (NCT01127464) | Rockefeller University | 2010-05-01 |
| Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 (NCT00993148) | Northwestern University | 2010-05-01 |
| Gene Transfer for HIV Using Autologous T Cells (NCT01153646) | City of Hope Medical Center | 2010-04-01 |
| Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily (NCT01121809) | Hospitales Universitarios Virgen del Rocío | 2010-04-01 |
| Cytomegalovirus Infection in Patients With HIV-1 Infection (NCT04067869) | University Hospital, Bordeaux | 2010-02-16 |
| Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients (NCT01017172) | Goethe University | 2009-11-01 |
| Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth (NCT01484522) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2009-10-01 |
| Surveillance of Kaletra in Korean Patients (NCT01083173) | AbbVie (prior sponsor, Abbott) | 2009-10-01 |
| Novel Interventions in HIV-1 Infection (NCT01130376) | Imperial College London | 2009-09-01 |
| A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects (NCT00833781) | Massachusetts General Hospital | 2009-08-01 |
| A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents (NCT00915655) | Tibotec Pharmaceuticals, Ireland | 2009-07-01 |
| Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults (NCT00892437) | Gilead Sciences | 2009-05-01 |
| Exploration of HIV Reservoirs (NCT01019044) | Objectif Recherche Vaccins SIDA | 2009-05-01 |
| Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection. (NCT00849160) | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | 2009-05-01 |
| A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients (NCT01092104) | Tobira Therapeutics, Inc. | 2009-02-01 |
| Etravirine Plus 2 Analogs in HIV-infected Patients (NCT01437241) | Hospitales Universitarios Virgen del Rocío | 2009-01-01 |
| A Phase 2 Study to Assess the Pharmacokinetics of Bevirimat 100 mg Tablets Given to HIV-1 Positive Patient for 15 Days (NCT01097070) | Myrexis Inc. | 2008-11-01 |
| A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054) (NCT01000818) | Merck Sharp & Dohme LLC | 2008-06-01 |
| HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy (NCT00709397) | Brigham and Women's Hospital | 2008-06-01 |
| Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection (NCT00642707) | CytoDyn, Inc. | 2008-03-01 |
| A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment). (NCT00534352) | Tibotec, Inc | 2008-01-01 |
| Fitness and Longevity in Exercise (NCT03399136) | University of Maryland, Baltimore | 2007-07-19 |
| Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients (NCT00481390) | GlaxoSmithKline | 2007-06-01 |
| HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults (NCT00450580) | ViiV Healthcare | 2007-03-01 |
| Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage (NCT00556634) | Sociedad Andaluza de Enfermedades Infecciosas | 2006-04-01 |
| Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine (NCT00743340) | Gilead Sciences | 2005-11-22 |
| A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults (NCT00242879) | ViiV Healthcare | 2005-08-01 |
| SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada (NCT00323687) | Gilead Sciences | 2004-09-01 |
| Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients (NCT00823966) | Pfizer | 2003-12-01 |
| A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019) (NCT00894114) | Merck Sharp & Dohme LLC | 2003-05-01 |
| Primary Infection Cohort (NCT03148964) | ANRS, Emerging Infectious Diseases | 1996-10-01 |
| Effect of Maraviroc (MCV) on the Immunological Recovery of HIV-1 Discordant Patients With CD4 Lymphocyte Counts Below 200 Cells/mm3 (NCT01235013) | Hospital Clinic of Barcelona | |